Patents by Inventor Taymar E. Hartman

Taymar E. Hartman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20200157230
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: January 31, 2020
    Publication date: May 21, 2020
    Inventors: Taymar E. HARTMAN, Paul W. SAUER, John E. BURKY, Mark C. WESSON, Ping Y. HUANG, Thomas J. ROBINSON, Braeden D. PARTRIDGE, J. Yun TSO
  • Vectors and host cells comprising a modified SV40 promoter for protein expression
    Publication number: 20190062797
    Abstract: The present disclosure is directed to expression vectors, comprising a weakened SV40 promoter, and recombinant mammalian cells capable of producing high levels of a polypeptide of interest, methods of generating and using such recombinant mammalian cells.
    Type: Application
    Filed: August 20, 2018
    Publication date: February 28, 2019
    Inventors: Taymar E. Hartman, J. Yun Tso, Yimin He
  • Vectors and host cells comprising a modified SV40 promoter for protein expression
    Patent number: 10053720
    Abstract: The present disclosure is directed to expression vectors, comprising a weakened SV40 promoter, and recombinant mammalian cells capable of producing high levels of a polypeptide of interest, methods of generating and using such recombinant mammalian cells.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: August 21, 2018
    Assignee: AbbView Biotherapeutics Inc.
    Inventors: Taymar E. Hartman, J. Yun Tso, Yimin He
  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20180127506
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: October 4, 2017
    Publication date: May 10, 2018
    Inventors: Taymar E. HARTMAN, Paul W. SAUER, John E. BURKY, Mark C. WESSON, Ping Y. HUANG, Thomas J. ROBINSON, Braeden D. PARTRIDGE, J. Yun TSO
  • DAC HYP compositions
    Patent number: 9815903
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: November 14, 2017
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Taymar E. Hartman, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP COMPOSITIONS
    Publication number: 20170247461
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: May 4, 2017
    Publication date: August 31, 2017
    Inventors: Taymar E. HARTMAN, Paul W. SAUER, John E. BURKY, Mark C. WESSON, Ping Y. HUANG, Thomas J. ROBINSON, Braeden D. PARTRIDGE, J. Yun TSO
  • DAC HYP compositions and methods
    Patent number: 9676860
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: June 13, 2017
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Taymar E. Hartman, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • VECTORS AND HOST CELLS COMPRISING A MODIFIED SV40 PROMOTER FOR PROTEIN EXPRESSION
    Publication number: 20160265018
    Abstract: The present disclosure is directed to expression vectors, comprising a weakened SV40 promoter, and recombinant mammalian cells capable of producing high levels of a polypeptide of interest, methods of generating and using such recombinant mammalian cells.
    Type: Application
    Filed: May 20, 2016
    Publication date: September 15, 2016
    Inventors: TAYMAR E. HARTMAN, J. YUN TSO, YIMIN HE
  • DAC HYP compositions and methods
    Patent number: 9340619
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: May 17, 2016
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Taymar E. Hartman, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP compositions and methods
    Patent number: 9260528
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Grant
    Filed: June 9, 2015
    Date of Patent: February 16, 2016
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Taymar E. Hartman, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20150274832
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: June 9, 2015
    Publication date: October 1, 2015
    Inventors: Taymar E. HARTMAN, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20150203583
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: January 21, 2015
    Publication date: July 23, 2015
    Inventors: Taymar E. HARTMAN, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20150197573
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: March 27, 2015
    Publication date: July 16, 2015
    Inventors: Taymar E. HARTMAN, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • VECTORS AND HOST CELLS COMPRISING A MODIFIED SV40 PROMOTER FOR PROTEIN EXPRESSION
    Publication number: 20140295497
    Abstract: The present disclosure is directed to expression vectors, comprising a weakened SV40 promoter, and recombinant mammalian cells capable of producing high levels of a polypeptide of interest, methods of generating and using such recombinant mammalian cells.
    Type: Application
    Filed: November 30, 2011
    Publication date: October 2, 2014
    Inventors: Taymar E. Hartman, J. Yun Tso, Yimin He
  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20120301429
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: May 25, 2012
    Publication date: November 29, 2012
    Inventors: Taymar E. HARTMAN, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden Partridge, J. Yun Tso
  • Method for producing a peptide with a pI above 8 or below 5
    Patent number: 6303340
    Abstract: A method is described for producing a peptide having a pI above 8 or below 5 wherein the peptide is expressed as a fusion protein in which it is linked to a fusion partner through an acid cleavage site. The peptide is released from the fusion partner by acid cleavage in the absence of chaotrope. The fusion partner and its acid cleavage products, if any, have a net charge sufficiently different from that of the desired peptide to allow isolation of the peptide by ion-exchange chromatography.
    Type: Grant
    Filed: July 8, 1999
    Date of Patent: October 16, 2001
    Assignee: Scios Inc.
    Inventors: N. Stephen Pollitt, Douglas I. Buckley, Peter A. Stathis, Taymar E. Hartman, Ziyang Zhong